Oak Grove Capital LLC Neu Base Therapeutics, Inc. Transaction History

Oak Grove Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$6.92 - $12.36 $132,691 - $237,003	-19,175 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$6.92 - $9.25 $5,536 - $7,400	-800 Reduced 4.01%	19,175 $134,000
Q3 2020 Nov 13, 2020	SELL	$7.25 - $9.71 $58,000 - $77,680	-8,000 Reduced 28.6%	19,975 $152,000
Q2 2020 Aug 24, 2020	BUY	$6.69 - $11.51 $187,152 - $321,992	27,975 New	27,975 $246,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Oak Grove Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Grove Capital LLC with notifications on news.